Elzonris Injection, Solution
Product Images NDC 72187-0401

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Elzonris (NDC 72187-0401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stemline Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1000 Mcgg/ml Vial Label (Elzonris 01)

N7/ ELZONRIS (tagraxofusp-erzs) injection is a medication that is diluted and administered intravenously, with a concentration of 1,000 mcg/mL. It is important to discard any unused portion of the single dose vial. This medication is produced by Stemline Therapeutics, Inc. and the product code is 72187-0401-1.*

FDA Label Image

1000 Mcgg/ml Carton Label (Elzonris 02)

ELZONRIS (tagraxofusp-erzs) injection is a medication that comes in a single-dose vial of 1,000 mcg/mL for intravenous infusion after dilution. It contains tagraxofusp-erzs, sodium chloride, sorbitol, tromethamine, and water for injection. ELZONRIS is used for treatment as prescribed by a doctor. The medication should be stored in a freezer between -25°C and -15°C and thawed between 15°C and 25°C for 15 to 30 minutes in the original carton. Thawed vials may be held at room temperature for approximately 1 hour prior to dosage preparation. The medication is manufactured and distributed by Stemline Therapeutics, Inc. For questions, call 8773327961.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.